What drives cash-pay landed cost on Refill
Landed cost in a cash-pay clinic is per-vial drug cost plus shipping, platform fees, software fees on transactions, and any provider or Refill Connect charges if you use those layers. Refill positions aggregate 503A pricing as leverage from network volume and advertises a price-match guarantee — attractive when solo pharmacy contracts are weak. The practical questions are the per-vial rate on your top SKUs after onboarding, what percentage software fee applies at your volume tier, and whether aggregate rates hold across refill cycles.
For cash-pay margin, fee stacking matters as much as the headline drug rate. A competitive aggregate price plus a 3–5% software fee on every transaction, monthly platform cost, and optional Connect or provider fees can narrow the spread you thought you had. Compare all-in landed cost on the same concentrations and supply durations — not marketing savings claims in isolation.